US healthcare contract development and manufacturing organization (CDMO) market was valued at $171.3 billion in 2025 and is growing at a CAGR of 6.4% during the forecast period 2026-2035. The US healthcare contract development and manufacturing organization (CDMO) market is experiencing steady growth as pharmaceutical and biotechnology companies increasingly outsource drug development and manufacturing to specialized partners. Rising demand for complex therapies, including biologics, sterile injectables, and high-potency small molecules, is driving the need for advanced technical capabilities and flexible manufacturing solutions. CDMOs are focusing on expanding their capacity, adopting automation, and implementing digital quality systems to improve efficiency and compliance. Long-term collaborations are becoming more common, as companies seek reliable partners to navigate regulatory complexities and accelerate time-to-market. Additionally, there is growing emphasis on localized manufacturing within the US to strengthen supply chain resilience and meet domestic demand. Overall, the market is evolving toward integrated, end-to-end service offerings that combine development, analytical testing, and commercial-scale production.

UK interleukin inhibitors market was valued at $2,426.4 million in 2025 and is projected to reach $6,006.7 million by 2035, growing at a CAGR of 9.5% during the forecast period (2026–2035). Interleukin inhibitors are targeted biologic therapies designed to modulate specific inflammatory pathways and are widely used in the treatment of autoimmune and chronic inflammatory diseases such as psoriasis, rheumatoid arthritis, atopic dermatitis, asthma, and inflammatory bowel disease. Market growth is driven by the rising prevalence of immune-mediated disorders, increasing adoption of biologics over conventional systemic therapies, and expanding reimbursement support through the National Health Service (NHS).

North America interleukin inhibitors market was valued at $15,869.7 million in 2025 and is projected to reach $45,240.0 million by 2035, growing at a CAGR of 11.1% during the forecast period (2026–2035). Interleukin inhibitors comprise biologic and targeted immunomodulatory therapies designed to block specific interleukin pathways such as IL-17, IL-23, IL-6, IL-4/13, and IL-5, and are widely used in the treatment of autoimmune and inflammatory disorders including psoriasis, psoriatic arthritis, rheumatoid arthritis, inflammatory bowel disease, asthma, and atopic dermatitis. Market growth is driven by the rising prevalence of chronic immune-mediated diseases, strong clinical efficacy of next-generation biologics, expanding indications, and favorable reimbursement frameworks across the United States and Canada.

Solar water pump market was valued at $2,200.2 million in 2025 and is projected to reach $4,794.0 million by 2035, growing at a CAGR of 8.2% during the forecast period (2026-2035). Solar water pumps are used to supply water for agricultural irrigation, livestock, residential, and industrial applications, offering a sustainable and energy-efficient alternative to conventional diesel or electric pumps. Market growth is being driven by increasing adoption of renewable energy solutions, government incentives for solar irrigation and water management, rising energy costs, and the growing need for sustainable water supply solutions in regions facing water scarcity and unreliable electricity access.

Europe personal care appliances market was valued at $5.8 billion in 2024 and is projected to reach $9.7 billion by 2035, growing at a CAGR of 4.8% during the forecast period (2025-2035). The European personal care appliances market is witnessing consistent expansion, supported by evolving consumer lifestyles, rising grooming awareness, and a strong emphasis on personal hygiene and appearance. Increasing urbanization, higher disposable incomes, and the growing influence of wellness-oriented living are encouraging consumers to adopt advanced grooming and beauty appliances for both home and professional use.

Asia-Pacific personal care appliances market was valued at $9.5 billion in 2024 and is projected to reach $19.0 billion by 2035, growing at a CAGR of 6.5% during the forecast period (2025-2035). The Asia-Pacific personal care appliances market is gaining strong momentum as rapid urban development, lifestyle modernization, and heightened awareness of personal grooming reshape consumer behavior across the region. Growing middle-class populations and increased participation in the workforce are expanding demand for convenient, at-home grooming and beauty solutions. Consumers are increasingly seeking appliances that combine performance, durability, and aesthetic appeal, encouraging manufacturers to introduce technologically enhanced and design-driven products.

US digital pathology market was valued at $515.5 million in 2025 and is projected to reach $3,387.5 million by 2035, growing at a CAGR of 20.8% during the forecast period (2026–2035). In the US digital pathology market, cloud-based solutions are increasingly adopted to manage the growing volume and complexity of pathology data. These platforms provide scalable infrastructure that reduces reliance on on-premise systems and supports efficient data storage and retrieval. Cloud deployment enables remote access to digital slides, facilitating collaboration among pathologists across geographically distributed healthcare facilities. It also supports integration with artificial intelligence tools used for image analysis and decision support. Subscription-based models associated with cloud platforms offer greater flexibility in cost management for healthcare organizations. Overall, cloud-based digital pathology aligns with the operational and analytical needs of multi-site health systems.

UK digital pathology market was valued at $77.8 million in 2025 and is projected to reach $528.9 million by 2035, growing at a CAGR of 21.2% during the forecast period (2026–2035). The UK digital pathology market is being increasingly driven by the rising prevalence of cancer and chronic diseases. According to Macmillan Cancer Support, nearly 3.5 million individuals are currently living with cancer and more than 420,000 individuals are diagnosed with cancer each year in the UK, highlighting the growing demand for timely and accurate diagnostic services. Digital pathology offers enhanced capabilities for tissue analysis, biomarker quantification, and remote consultation, which can support faster and more consistent diagnoses. The increasing patient burden is driving healthcare providers to adopt technology-driven solutions that improve workflow efficiency and diagnostic accuracy. Additionally, the need for scalable and standardized pathology services in both oncology and chronic disease management is becoming more pronounced.

North America digital pathology market was valued at $531.5 million in 2025 and is projected to reach $3,492.3 million by 2035, growing at a CAGR of 20.8% during the forecast period (2026–2035). The North American digital pathology market is increasingly shifting from traditional analog methods toward digitally enabled workflows. Pathology laboratories are adopting whole slide imaging and digital platforms to improve workflow consistency and enable remote review. This transition is supported by growing integration of digital systems with laboratory information systems and hospital networks. Regulatory acceptance and clinical validation have contributed to wider routine use in diagnostic settings. Adoption remains uneven, with larger institutions moving faster than smaller laboratories. Overall, the market reflects a measured transition rather than a rapid transformation.

India digital pathology market was valued at $30.2 million in 2025 and is projected to reach $284.6 million by 2035, growing at a CAGR of 25.2% during the forecast period (2026–2035). The growing adoption of digital pathology consultation in India reflects a broader shift toward technology-enabled diagnostic practices. Increasing case volumes, coupled with a shortage of specialized pathologists in certain regions, has encouraged healthcare institutions to use digital platforms for remote slide review and expert consultations. Digital pathology enables faster case sharing and second opinions without the logistical constraints of physical slide transport. It also supports collaboration between tertiary care centers and smaller laboratories, improving access to specialized diagnostic expertise. Advancements in whole-slide imaging and secure data transmission have enhanced reliability and acceptance among clinicians. Additionally, the integration of digital workflows helps standardize reporting and reduce turnaround times. Together, these factors are contributing to the steady growth of digital pathology consultation across India.